InMed Pharmaceuticals Inc. announced that Sarah Li, promoted to Vice President of Accounting and Controller and Principal Accounting Officer. Ms. Li has served as the Company's controller since January 2020. Prior to that, she was Controller of GoldMining Inc. from March 2017 until September 2019.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3033 USD | -3.71% | +2.85% | -27.09% |
05-14 | Earnings Flash (INM) INMED PHARMACEUTICALS Posts Q3 Revenue $1.2M | MT |
05-14 | InMed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.09% | 1.84M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- INM Stock
- News InMed Pharmaceuticals Inc.
- Inmed Pharmaceuticals Inc. Announces Promotion of Sarah Li to Controller and Principal Accounting Officer